Floatz logo

Imc-1

Myofascial Pain Syndrome

Innovative Med Concepts, LLCUNKNOWNPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Myofascial Pain Syndrome cohort.

Asset / SponsorPhaseRating
Granisetron
Karolinska Institutet
Phase 4BB
Capsaicin
Stamford Hospital
Phase 2CCC
Solvazinc
Cairo University
Early Phase 1C
Prilocaine
Bursa City Hospital
N/AD
Baclofen
Saint Petersburg State University, Russia
UnknownD

View all 11 →

Same molecule, other indications

Imc-1 is also rated in:

fibromyalgiaDormant
B
Indicative · Phase 2
57 / 100
View asset →
chronic pain syndromeDormant
CCC
Indicative · Phase 2
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →